# Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

> **NCT01358357** · PHASE3 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 965 (actual)

## Conditions studied

- Bipolar I Disorder

## Interventions

- **DRUG:** Lurasidone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01358357
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 965 (ACTUAL)
- **Last updated:** 2016-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01358357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01358357, "Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01358357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*